Literature DB >> 6497897

Kinetics and mechanism of in vitro uptake of amino-beta-lactam antibiotics by rat small intestine and relation to the intact-peptide transport system.

E Nakashima, A Tsuji, H Mizuo, T Yamana.   

Abstract

By utilizing the everted jejunum of rats, the initial uptake rates of several antibiotics were measured over a wide range of concentrations. The uptakes followed mixed-type kinetics involving saturable and non-saturable processes in parallel. The pertinent kinetic parameters for the uptake of each antibiotic were determined. The effect of cephalexin on the uptake of cyclacillin obeyed competitive inhibition kinetics, and the inhibition constant Ki was found to be equal to the Michaelis constant Kt for the uptake of cephalexin itself. In a similar way, the uptake of cephalexin was inhibited by cyclacillin. Uptakes of both cyclacillin and cephalexin were reduced significantly by several metabolic inhibitors. From the effect of temperature on the uptakes of cyclacillin and cephalexin, activation energies of 24.8 and 23.1 kcal/mole were obtained respectively. These results indicate the involvement of an active transport mechanism for cyclacillin and cephalexin. It was found that several dipeptides markedly inhibited the uptakes of cyclacillin and cefadroxil. Furthermore, the uptake of glycylglycine, a typical dipeptide, was inhibited by cyclacillin, cefadroxil, cephalexin, and cephradine. The kinetics of mutual inhibition of the uptakes of cyclacillin and glycylglycine were consistent with competitive-type inhibition. This is the first report which establishes, from a kinetic point of view, the involvement of a common transport system in the in vitro uptakes of the dipeptides and the antibiotics.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6497897     DOI: 10.1016/0006-2952(84)90104-7

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  8 in total

1.  Ibuprofen is a non-competitive inhibitor of the peptide transporter hPEPT1 (SLC15A1): possible interactions between hPEPT1 substrates and ibuprofen.

Authors:  Diana Højmark Omkvist; Birger Brodin; Carsten Uhd Nielsen
Journal:  Br J Pharmacol       Date:  2010-12       Impact factor: 8.739

2.  Quantitative evaluation of PEPT1 contribution to oral absorption of cephalexin in rats.

Authors:  Takanori Hironaka; Shota Itokawa; Ken-ichi Ogawara; Kazutaka Higaki; Toshikiro Kimura
Journal:  Pharm Res       Date:  2008-09-11       Impact factor: 4.200

3.  A quantitative structure-activity relationship for translocation of tripeptides via the human proton-coupled peptide transporter, hPEPT1 (SLC15A1).

Authors:  Diana Højmark Omkvist; Simon Birksø Larsen; Carsten Uhd Nielsen; Bente Steffansen; Lars Olsen; Flemming Steen Jørgensen; Birger Brodin
Journal:  AAPS J       Date:  2010-05-08       Impact factor: 4.009

4.  Low bioavailability of amoxicillin in rats as a consequence of presystemic degradation in the intestine.

Authors:  J Chesa-Jiménez; J E Peris; F Torres-Molina; L Granero
Journal:  Antimicrob Agents Chemother       Date:  1994-04       Impact factor: 5.191

5.  Oral cyclacillin interacts with the absorption of oral ampicillin, amoxycillin, and bacampicillin.

Authors:  J Sjövall; G Alván; D Westerlund
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

6.  Expression and protein kinase C-dependent regulation of peptide/H+ co-transport system in the Caco-2 human colon carcinoma cell line.

Authors:  M Brandsch; Y Miyamoto; V Ganapathy; F H Leibach
Journal:  Biochem J       Date:  1994-04-01       Impact factor: 3.857

7.  Peptide carrier-mediated transport in intestinal brush border membrane vesicles of rats and rabbits: cephradine uptake and inhibition.

Authors:  H Yuasa; G L Amidon; D Fleisher
Journal:  Pharm Res       Date:  1993-03       Impact factor: 4.200

8.  Transport characteristics of ceftibuten, a new oral cephem, in rat intestinal brush-border membrane vesicles: relationship to oligopeptide and amino beta-lactam transport.

Authors:  N Muranushi; T Yoshikawa; M Yoshida; T Oguma; K Hirano; H Yamada
Journal:  Pharm Res       Date:  1989-04       Impact factor: 4.200

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.